Caseware UK (AP4) 2023.0.135 2023.0.135 2023-11-302023-11-30false2022-12-01No description of principal activityThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.11truetrue 11706167 2022-12-01 2023-11-30 11706167 2021-12-01 2022-11-30 11706167 2023-11-30 11706167 2022-11-30 11706167 c:Director1 2022-12-01 2023-11-30 11706167 d:CurrentFinancialInstruments 2023-11-30 11706167 d:CurrentFinancialInstruments 2022-11-30 11706167 d:CurrentFinancialInstruments d:WithinOneYear 2023-11-30 11706167 d:CurrentFinancialInstruments d:WithinOneYear 2022-11-30 11706167 d:ShareCapital 2023-11-30 11706167 d:ShareCapital 2022-11-30 11706167 d:RetainedEarningsAccumulatedLosses 2023-11-30 11706167 d:RetainedEarningsAccumulatedLosses 2022-11-30 11706167 c:OrdinaryShareClass1 2022-12-01 2023-11-30 11706167 c:OrdinaryShareClass1 2023-11-30 11706167 c:FRS102 2022-12-01 2023-11-30 11706167 c:AuditExempt-NoAccountantsReport 2022-12-01 2023-11-30 11706167 c:FullAccounts 2022-12-01 2023-11-30 11706167 c:PrivateLimitedCompanyLtd 2022-12-01 2023-11-30 xbrli:shares iso4217:GBP xbrli:pure

Registered number: 11706167









KENSINGTON THERAPY LTD







UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 30 NOVEMBER 2023

 
KENSINGTON THERAPY LTD
REGISTERED NUMBER: 11706167

STATEMENT OF FINANCIAL POSITION
AS AT 30 NOVEMBER 2023

2023
2022
Note
£
£

Current assets
  

Debtors
  
18,448
12,909

Cash at bank and in hand
  
1,903
425

  
20,351
13,334

Creditors: amounts falling due within one year
 4 
(4,680)
(4,016)

  

Net assets
  
15,671
9,318


Capital and reserves
  

Called up share capital 
 5 
1
1

Profit and loss account
  
15,670
9,317

  
15,671
9,318


The director considers that the company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 4 September 2024.




S Fianco
Director

The notes on pages 2 to 4 form part of these financial statements.
Page 1

 
KENSINGTON THERAPY LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2023

1.


General information

Kensington Therapy Ltd is a private company limited by shares and registered in England & Wales. The address of its registered office is 87 Earls Court Road, London, W8 6EF.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The company's functional and presentational currency is GBP.

The following principal accounting policies have been applied:

 
2.2

Going concern

The company meets its day to day working capital requirements through its own resources and  financial support from its shareholders.
After reviewing the company's forecast and projection the director has a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis in preparing its financial statements.

 
2.3

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts.
Revenue from therapy service is recognised when the service is deemed to have been delivered to customer and, to the extent that, the entity has met its obligation under its service contract.
Revenue from rental of practice facility is recognised in the period in which the income becomes due.

 
2.4

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates income.

 
2.5

Debtors

Short term debtors are measured at transaction price, less any impairment.

Page 2

 
KENSINGTON THERAPY LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2023

2.Accounting policies (continued)

 
2.6

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours.

 
2.7

Creditors

Short term creditors are measured at the transaction price.

 
2.8

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.


3.


Employees

The average monthly number of employees, including directors, during the year was 1 (2022 - 1).


4.


Creditors: Amounts falling due within one year

2023
2022
£
£

Corporation tax
3,607
1,965

Other creditors
73
1,051

Accruals and deferred income
1,000
1,000

4,680
4,016


Page 3

 
KENSINGTON THERAPY LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2023

5.


Share capital

2023
2022
£
£
Allotted, called up and fully paid



1 Ordinary share of £1.00
1
1



6.


Related party transactions

At the reporting date, the company owed £73 (2022: £1,051) to its director. 


7.


Controlling party

The company is controlled by its director by virtue of her shareholding.
 
Page 4